Tomorrow.Bio key facts
as of Oct 2026- Provider of a cryopreservation service intended for long-term biological storage.
- Tomorrow.Bio is valued at approximately $28.2M as of Oct 2026 (last reported valuation).
- It has raised $8.2M; the latest was Seed Round ($5.6M) in May 2025.
- Notable investors include Zain S Hasan Charitable Remainder Trust, Blast.Club, TruVenturo, Asia Venture Group, TEC Ventures (Germany) — 6 tracked in total.
- Status: Privately Held (backing).
Tomorrow.Bio's last reported valuation, May 2025. Nothing priced has surfaced since.
- ·Watch Tomorrow.Bio: the Monday email on marks, rounds and moves
Tomorrow.Bio funding rounds
No funding rounds for Tomorrow.Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Tomorrow.Bio valuation
Tomorrow.Bio's last reported valuation was $28.2 million in May 2025. No priced round, secondary trade or fund mark has surfaced since.
Tomorrow.Bio investors
6 investors are on record for Tomorrow.Bio, including Zain S Hasan Charitable Remainder Trust, Blast.Club, TruVenturo and Asia Venture Group.
About Tomorrow.Bio
Provider of a cryopreservation service intended for long-term biological storage. The company utilizes advanced cooling techniques and specialized preservation methods to maintain individuals at low temperatures, ensuring cellular integrity while preventing ice crystal formation, enabling individuals who are seeking future medical advancements to potentially benefit from emerging technologies that may allow revival and treatment beyond current medical limitations.
- Sector
- Healthcare
- HQ
- Berlin, Germany
- Founded
- 2020
- Employees
- 20
- Website
- tomorrow.bio/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.